Association of variants in angiotensin-converting enzyme and endothelin-1 genes with phototherapy in cutaneous T-cell lymphoma

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 13, Issue 4, 2004, Pages 111-118

  Vaškù, Vladimír ^a   Vaškù, Julie Anna ^b   Goldbergová, Monika Pávková ^b   Vaškù, Anna ^b  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Endothelin 1 gene polymorphism; I D ACE; Mycosis fungoides

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1;

ADULT; AGE DISTRIBUTION; AGED; ANGIOGENESIS; ARTICLE; CELL INFILTRATION; CLONAL VARIATION; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; FAMILY HISTORY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTOTHERAPY; SEX RATIO;

EID: 11244253896     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Strasly M, Cavallo F, Geuna M et al. IL-12 Inhibition of Endothelial Cell Functions and Angiogenesis Depends on Lymphocyte-Endothelial Cell Cross-Talk. Immunol 2001; 166: 3890-9.
2. Pober JS, Cotran RS. Immunologic interactions of T lymphocytes with vascular endothelium. Adv Immunol 1991; 50: 261-302.
3. Choi J, Enis DR, Koh KP et al. T lymphocyte-endothelial cell interactions. Ann Rev Immunol 2004; 22: 683-709.
4. Pober JS, Kluger MS, Schechner JS. Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann N Y Acad Sci 2001; 941: 12-25.
5. Baron ED, Stevens SR. Phototherapy for cutaneous T-cell lymphoma. Dermatol Ther 2003; 16: 303-10.
6. Yamauchi R, Morita A, Yasuda Y et al. Different susceptibility of malignant versus nonmalignant human T cells toward ultraviolet A-I radiation-induced apoptosis. J Invest Dermatol 2004; 122: 477-83.
7. Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis. Oncogene 2004; 23: 317-29.
8. Eisenlohr LC, Bacik I, Bennink JR et al. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 1992; 71: 963-72.
9. Bramucci M, Miano A, Quassinti L et al. Degradation of thymic humoral factor gamma2 by human plasma: involvement of angiotensin converting enzyme. Regul Pept 2003; 111: 199-205.
10. Odaka C, Mizuochi T. Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals. Clin Exp Immunol 2000; 121: 515-22.
11. Petrov V, Fagard R, Lijnen P. Effect of protease inhibitors on angiotensin-converting enzyme activity in human lymphocytes. Am J Hypertens 2000; 13: 535-9.
12. Mailloux A, Deslandes B, Vaubourdolle M et al. Captopril and enalaprilat decrease antioxidant defences in human endothelial cells and are unable to protect against apoptosis. Cell Biol Int 2003; 27: 825-30.
13. Alvarez A, Cerda-Nicolas M, Naim Abu Nabah Y et al. Direct evidence of leukocyte adhesion in arterioles by angiotensin II. Blood 2004; 104: 402.
14. Filippatos G, Uhal BD. Blockade of apoptosis by ACE inhibitors and angiotensin receptor antagonists. Curr Pharm Des 2003; 9: 707-14.
15. Brown RE, Nazmi RK. The Reed-Steinberg cell: molecular characterization by proteomic analysis therapeutic implications. Ann Clin Lab Sci 2002; 32: 339-51.
16. Wu J, Akaike T, Hayashida K et al. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 2002; 98: 29-35.
17. Bagnato A, Natali PG. Endothelin receptors as novel targets in tumor therapy. J Transl Med 2004; 2: 16.
18. Salani D, Taraboletti G, Rosanò L et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo Am J Pathol 2000; 157: 1703-1711.
19. Tada A, Suzuku I, Im S et al. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocates and participates in the responses to ultraviolet radiation. Cell Growth Differ 1998; 9: 575-84.
20. Rigat B, Hubert C, Corvol P et al. PCR detection of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucl Acids Res 1992; 20: 1433.
21. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl 1993; 3: 120-1.
22. Vaškù A, Špinarová L, Goldbergová M et al. The double heterozygote of two endothelin-1 gene polymorphisms (G8002A and -3A/-4A) is related to big endothelin levels in chronic heart failure. Exp Mol Pathol 2002; 73: 230-3.
23. Scarisbrick JJ, Woolford AJ, Russell-Jones R et al. Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q and 17p. J Invest Dermatol 2001; 117: 663-70.
24. Costerousse O, Allegrini J, Lopez M et al. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290: 33-40.
25. Yeung JH. A comparison of the effects of angiotensin-converting enzyme inhibitors with bradykinin, angiotensin II and their specific antagonists on concanavalin A-induced proliferation of mouse T-lymphocytes. Methods Find Exp Clin Pharmacol 1994; 16: 163-72.
26. Spinella F, Rosanò L, Di Castro V et al. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor 1α in ovarian carcinoma cells. J Biol Chem 2002; 77: 27850-5.
27. Gupta RA, Tejada LV, Tong BJ et al. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res 2003; 63: 906-11.